Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 20, 2014
CKAP4 inhibited growth and metastasis of hepatocellular carcinoma through regulating EGFR signalingShuang-Xi Li, Li-Juan Liu, Li-Wei Dong, et al.
Science Translational Medicine|September 24, 2020
PTEN status determines chemosensitivity to proteasome inhibition in cholangiocarcinomaTian-Yi Jiang, Yu-Fei Pan, Zheng-Hua Wan, et al.
Cell Death & Disease|April 29, 2024
Arsenic trioxide augments immunogenic cell death and induces cGAS-STING-IFN pathway activation in hepatocellular carcinomaXin Li, Yu-Fei Pan, Yi-Bin Chen, et al.
Proteomics|March 11, 2005
Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma: Identification of potential tumor markersChen Li, Ye-Xiong Tan, Hu Zhou, et al.
Molecular & Cellular Proteomics : MCP|November 1, 2003
From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasisShi-Jian Ding, Yan Li, Ye-Xiong Tan, et al.
Clinical and Translational Medicine|May 1, 2024
Bortezomib in previously treated phosphatase and tension homology-deficient patients with advanced intrahepatic cholangiocarcinoma: An open-label, prospective and single-centre phase II trialTian-Mei Zeng, Tian-Yi Jiang, Guang Yang, et al.
Hepatology (Baltimore, Md.)|September 7, 2004
Negative regulation of hepatocellular carcinoma cell growth by signal regulatory protein alpha1He-Xin Yan, Hong-Yang Wang, Rui Zhang, et al.
Cancer|May 28, 2014
Prognostic significance of cytoskeleton-associated membrane protein 4 and its palmitoyl acyltransferase DHHC2 in hepatocellular carcinomaShuang-Xi Li, Gu-Sheng Tang, Dong-Xun Zhou, et al.
Cancer Letters|December 20, 2025
Lidocaine potentiates thermal ablation in cholangiocarcinoma by modulating TRPV6-Driven ca2+/PI3K/AKT/HSF-1 signaling pathwayPing-Ping Chen, Yun-Kai Lin, Ming-Xing Xia, et al.
Journal of Hepatology|May 8, 2016
ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1αFu-Quan Wu, Tian Fang, Le-Xing Yu, et al.
Pageof 5